Sonoma Pharmaceuticals, Inc. (SNOA)
1.09
-0.09
(-7.63%)
USD |
NASDAQ |
May 15, 16:00
1.09
0.00 (0.00%)
After-Hours: 20:00
Sonoma Pharmaceuticals EPS Diluted (Quarterly) : -0.4781 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Johnson & Johnson | 2.141 |
| Eli Lilly & Co. | 8.255 |
| Merck & Co., Inc. | -1.715 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.819M |
| Revenue (Quarterly) | 4.349M |
| Total Expenses (Quarterly) | 5.168M |
| Enterprise Value | -0.0196M |
| Gross Profit Margin (Quarterly) | 37.94% |
| Profit Margin (Quarterly) | -18.83% |
| Earnings Yield | -187.0% |
| Normalized Earnings Yield | -186.98 |